Trademark Overview
On Tuesday, July 16, 2024, a trademark application was filed for ARTEMETRX GENECO with the United States Patent and Trademark Office. The USPTO has given the ARTEMETRX GENECO trademark a serial number of 98650240. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, February 7, 2025. This trademark is owned by Edgewood Partners Insurance Center. The ARTEMETRX GENECO trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmacy benefit consulting, namely, consulting services for health and pharmacy benefit plan sponsors in the field of consumer health care insurance plan options
Business consulting services; Business management consulting; Business organization consulting; Analyzing and compiling data for measuring the performance of pharmacies and pharmacy programs; Insurance claims auditing, namely, auditing of pharmacy benefit claims data; Business auditing; Forensic accounting services; Negotiations of business contracts for pharmacy benefit programs for others; Business consulting services, namely, business administration assistance with development and scoring of requests for proposals; Pharmaceutical cost management services relating to pharmaceutical drug programs for health care facilities, employers, labor unions, and health insurance plans; Business organization consulting, namely, business data analysis and reporting to provide recommendations for medication spending in pharmacy benefit plans; Pharmacy business management services, namely, analysis of business data related to market trends in medication spending for pharmacy benefit plans; Analyzin...
Providing online, non-downloadable software to access a contract pharmacy network for evaluating and monitoring performance of prescription drug programs; providing online, non-downloadable software for analyzing drug spend to facilitate enhanced cost management for plan sponsors; providing online, non-downloadable software for analyzing and predicting patient need for gene therapies to facilitate enhanced cost management for plan sponsors